Low Cardiac Output Syndrome After Cardiac Surgery: A Life-Threatening Condition from the Perspective of Pediatric Intensivists.


Journal

Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir
ISSN: 1308-4488
Titre abrégé: Turk Kardiyol Dern Ars
Pays: Turkey
ID NLM: 9426239

Informations de publication

Date de publication:
06 2022
Historique:
entrez: 13 6 2022
pubmed: 14 6 2022
medline: 15 6 2022
Statut: ppublish

Résumé

Low cardiac output syndrome is a clinical picture insourcing from insufficient oxygen sup- ply to tissues so as to meet the metabolic demand, myocardial dysfunction, and cardiovas- cular insufficiency. Low cardiac output syndrome is seen in nearly 25% of pediatric patients who underwent corrective or palliative surgery due to congenital heart defects. It is a clinical condition occurring typically 6-18 hours after surgery in pediatric patients undergoing cardiac surgery and causes organ failure, prolonged hospital and intensive care hospitalization time, increased resource utilization, and mortality. The identification and correct management of this serious complication in the early period is very important. However, there is no clear con- sensus or consensus report on the follow-up of this patient group and the definition of low cardiac output syndrome. Clinicians generally produced low cardiac output syndrome defini- tions according to their own approach. In this review, we aim to draw attention to low cardiac output syndrome and hope to summarize the pathophysiology, etiology, clinical definition, and treatment options of low cardiac output syndrome as a life-threatening condition in pediatric intensive care unit.

Identifiants

pubmed: 35695365
doi: 10.5543/tkda.2022.21212
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

284-292

Auteurs

Nagehan Aslan (N)

Department of Pediatric Intensive Care, Malatya Training and Research Hospital, Malatya, Turkey.

Dincer Yildizdas (D)

Department of Pediatric Intensive Care, Çukurova University Faculty of Medicine, Adana, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH